Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Japan's Mitsubishi Corp took a 52.2 billion yen ($342.4 million) impairment charge on its domestic offshore wind projects in ...

Mitsubishi UFJ Financial Group's dividend yield and buyback program boost value. Learn why MUFG stock is a solid investment ...

Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...

Mitsubishi Corp on Monday said it is reviewing how to proceed with its offshore wind projects in Japan given a "significantly ...

Japan's Mitsubishi Corp posted on Thursday a 19% increase in nine-month net profit to December to 827.4 billion yen ($5.43 ...

The Montero Sport is available at Qatar Automobiles Company, the authorized general distributor of Mitsubishi Motors in Qatar ...

Reports suggest that Honda’s proposal to make Nissan a subsidiary in their planned merger has negatively impacted the ...

Despite production ending in 1986, the aircraft is still flying around today and is popular due to its dependability and ...

Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...

Mitsubishi Motors is facing a tough financial year, with the company slashing its net profit forecast by a staggering 76%.